Craft

Aquinnah Pharmaceuticals

Total Funding

$19.8 M

Aquinnah Pharmaceuticals Summary

Company Summary

Overview
Aquinnah Pharmaceuticals is a company that specializes in developing drugs for neurodegenerative diseases. It develops technologies that remove the pathologic biomolecular condensates and prevent the progression of amyotrophic lateral sclerosis, Alzheimer's disease, and other neurological disorders.
Type
Private
Status
Active
Founded
2014
HQ
Cambridge, MA, US | view all locations
Website
https://www.aquinnahpharma.com
Cybersecurity rating
Sectors

Key People

  • Glenn Larsen

    Glenn Larsen, Co-Founder, President & CEO

  • Ben Wolozin

    Ben Wolozin, Co-Founder & Chief Scientific Officer

  • Daniel Geffken

    Daniel Geffken, Chief Financial Officer

  • Joe Vacca

    Joe Vacca, Vice President, Medicinal Chemistry

LocationsView all

1 location detected

  • Cambridge, MA HQ

    United States

    750 Main St

Footer menu